These findings suggest that the expression of PDK4, RBPMS2, and PDE5A in PBMCs could predict the expression levels of these genes in lung tissues and might serve as circulating potential biomarkers and/or therapeutic targets for IPAH patients. The gene discussed is PDK4; the disease is idiopathic pulmonary arterial hypertension.